Showing results (221-230 of 777) with videos related to

Sort By:
Pageof 78
Blood|July 16, 2005
Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myelomaPaul Gerard Guy Richardson, Bart Barlogie, James Berenson, et al.
Leukemia|January 27, 2022
Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myelomaSophia Adamia, Shruti Bhatt, Kenneth Wen, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 7, 2024
Exploring the anti-myeloma potential of composite nanoparticles As4S4/Fe3O4: Insights from in vitro, ex vivo and in vivo studiesDanka Cholujova, Zdenka Lukacova Bujnakova, Erika Dutkova, et al.
British Journal of Haematology|April 16, 2008
Fatty acid synthase is a novel therapeutic target in multiple myelomaYutaka Okawa, Teru Hideshima, Hiroshi Ikeda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2011
Significant biological role of sp1 transactivation in multiple myelomaMariateresa Fulciniti, Samir Amin, Puru Nanjappa, et al.
Blood|October 25, 2008
SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating signaling via Akt and ERKYutaka Okawa, Teru Hideshima, Paul Steed, et al.
Blood|July 2, 2002
Absence of biologically important Kaposi sarcoma-associated herpesvirus gene products and virus-specific cellular immune responses in multiple myelomaChristian Brander, Noopur Raje, Paula G O'Connor, et al.
Cancer Research|July 5, 2005
Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myelomaYu-Tzu Tai, Xianfeng Li, Xia Tong, et al.
Advanced Healthcare Materials|September 24, 2021
A 3D-Bioprinted Multiple Myeloma ModelDi Wu, Zongyi Wang, Jun Li, et al.
Leukemia|April 10, 2019
Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myelomaYan Song, Paul M C Park, Lei Wu, et al.
Pageof 78